Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000262603 | SCV000355700 | uncertain significance | Chédiak-Higashi syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000262603 | SCV001098993 | likely benign | Chédiak-Higashi syndrome | 2024-12-30 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV000262603 | SCV001520280 | uncertain significance | Chédiak-Higashi syndrome | 2019-09-13 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. |
Ambry Genetics | RCV002520467 | SCV003698476 | uncertain significance | Inborn genetic diseases | 2021-05-24 | criteria provided, single submitter | clinical testing | The c.10477T>C (p.F3493L) alteration is located in exon 46 (coding exon 44) of the LYST gene. This alteration results from a T to C substitution at nucleotide position 10477, causing the phenylalanine (F) at amino acid position 3493 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV005238867 | SCV005887408 | likely benign | not specified | 2025-01-13 | criteria provided, single submitter | clinical testing | Variant summary: LYST c.10477T>C (p.Phe3493Leu) results in a non-conservative amino acid change in the encoded protein sequence. Two of four in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00011 in 1607052 control chromosomes, predominantly at a frequency of 0.0039 within the Ashkenazi Jewish subpopulation in the gnomAD database (v4.1 dataset). The observed variant frequency within Ashkenazi Jewish control individuals in the gnomAD database is approximately 3.5-fold of the estimated maximal expected allele frequency for a pathogenic variant in LYST causing Chediak-Higashi Syndrome phenotype (0.0011). To our knowledge, no occurrence of c.10477T>C in individuals affected with Chediak-Higashi Syndrome and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 296355). Based on the evidence outlined above, the variant was classified as likely benign. |